Sarepta

Completing steps towards success checkmark on cubes symbolizing progress
Biotech

Sarepta's big bet on Arrowhead's siRNA assets yields early data

Sarepta shared clinical data on two siRNA candidates, delivering an early look at the wisdom of its decision to bet big on Arrowhead’'s pipeline.
Nick Paul Taylor Mar 25, 2026 9:35am
Completing steps towards success checkmark on cubes symbolizing progress

Sarepta shares safety update on DM1 RNA med

Nov 24, 2025 4:00pm
Stock exchange concept

Sarepta sells 9M Arrowhead shares for $174M cash

Aug 13, 2025 5:44pm
sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

Jul 28, 2025 6:02pm
timer sand clocks time

Arrowhead meets $100M milestone, awaits Sarepta payment

Jul 28, 2025 3:10pm
FDA
Favicon Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm